MicroRNA‐132/212 Upregulation Inhibits TGF‐β‐Mediated Epithelial–Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4. Issue 16 (16th August 2016)
- Record Type:
- Journal Article
- Title:
- MicroRNA‐132/212 Upregulation Inhibits TGF‐β‐Mediated Epithelial–Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4. Issue 16 (16th August 2016)
- Main Title:
- MicroRNA‐132/212 Upregulation Inhibits TGF‐β‐Mediated Epithelial–Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4
- Authors:
- Fu, Weiwei
Tao, Tao
Qi, Mei
Wang, Lin
Hu, Jing
Li, Xinjun
Xing, Naidong
Du, Ran
Han, Bo - Abstract:
- Abstract : BACKGROUND: MicroRNAs (miRNAs) are noncoding RNAs that are important for embryonic stem cell development and epithelial to mesenchymal transition (EMT). Accumulating evidence indicates that miRNAs play critical roles in prostate cancer (PCa) metastasis and have potential use as therapeutic targets. Although dysregulated miR‐132/212 have been suggested to be directly involved in the proliferation and invasion of multiple malignancies, the exact role of miR‐132/212 in PCa has not yet been fully understood. METHODS: Real‐time quantitative PCR (RT‐qPCR) and bioinformatics analysis were used to validate the expression levels of miR‐132/212 in PCa cell lines as well as in prostatic tissues. The biological function of miR‐132/212 was evaluated by MTS, transwell, and wound healing assays, respectively. RT‐qPCR and Western blot were used to study the transcript and protein expression levels. Bioinformatics tools and luciferase reporter assay were utilized to identify the molecular target of miR‐132/212. Immunohistochemistry (IHC) was used to detect the expression of SOX4. RESULTS: miR‐132 and miR‐212 from the same gene cluster are downregulated in human PCa tissues when compared with benign prostatic hyperplasia tissues (both P < 0.05). Functionally, upregulation of miR‐132/212 inhibits the migration and invasive capacity of Vcap and Lncap cells by wound‐healing and transwell assays, respectively. Notably, overexpression of miR‐132/212 could inhibit TGF‐β (transformingAbstract : BACKGROUND: MicroRNAs (miRNAs) are noncoding RNAs that are important for embryonic stem cell development and epithelial to mesenchymal transition (EMT). Accumulating evidence indicates that miRNAs play critical roles in prostate cancer (PCa) metastasis and have potential use as therapeutic targets. Although dysregulated miR‐132/212 have been suggested to be directly involved in the proliferation and invasion of multiple malignancies, the exact role of miR‐132/212 in PCa has not yet been fully understood. METHODS: Real‐time quantitative PCR (RT‐qPCR) and bioinformatics analysis were used to validate the expression levels of miR‐132/212 in PCa cell lines as well as in prostatic tissues. The biological function of miR‐132/212 was evaluated by MTS, transwell, and wound healing assays, respectively. RT‐qPCR and Western blot were used to study the transcript and protein expression levels. Bioinformatics tools and luciferase reporter assay were utilized to identify the molecular target of miR‐132/212. Immunohistochemistry (IHC) was used to detect the expression of SOX4. RESULTS: miR‐132 and miR‐212 from the same gene cluster are downregulated in human PCa tissues when compared with benign prostatic hyperplasia tissues (both P < 0.05). Functionally, upregulation of miR‐132/212 inhibits the migration and invasive capacity of Vcap and Lncap cells by wound‐healing and transwell assays, respectively. Notably, overexpression of miR‐132/212 could inhibit TGF‐β (transforming growth factor‐β)‐induced EMT in Vcap and Lncap cells at both the mRNA and protein expression levels. SOX4 gene, an important EMT regulator of PCa, was identified as the target of miR‐132/212 by bioinformatics tools and luciferase reporter assay. Clinically, miR‐132/212 expression levels were adversely correlated with Gleason score ( P < 0.001) and SOX4 expression by IHC and RT‐qPCR in PCa tissues. CONCLUSION: Our data suggested that miR‐132/212 may act as tumor suppressors in PCa progression through disrupting EMT process by directly targeting SOX4. Prostate 76:1560–1570, 2016 . © 2016 Wiley Periodicals, Inc. … (more)
- Is Part Of:
- Prostate. Volume 76:Issue 16(2016)
- Journal:
- Prostate
- Issue:
- Volume 76:Issue 16(2016)
- Issue Display:
- Volume 76, Issue 16 (2016)
- Year:
- 2016
- Volume:
- 76
- Issue:
- 16
- Issue Sort Value:
- 2016-0076-0016-0000
- Page Start:
- 1560
- Page End:
- 1570
- Publication Date:
- 2016-08-16
- Subjects:
- MiR‐132 -- MiR‐212 -- prostate cancer -- SOX4 -- epithelial–mesenchymal transition
Prostate -- Diseases -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0045 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/pros.23241 ↗
- Languages:
- English
- ISSNs:
- 0270-4137
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6935.194000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2613.xml